Familial adenomatous polyposis primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}} {{AE}} {{SSH}}, {{MJK}}
{{CMG}} {{AE}} {{SSH}}, {{MJK}}
==Overview==
==Overview==
Effective measures for the [[Prevention (medical)|primary prevention]] of familial adenomatous polyposis include [[genetic counseling]].  
Effective measures for the [[Prevention (medical)|primary prevention]] of familial adenomatous polyposis include [[genetic counseling]]. The most common method is direct sequencing of the [[APC (gene)|''APC'' gene]].  
==Primary prevention==
==Primary prevention==
*Effective measures for the [[Prevention (medical)|primary prevention]] of familial adenomatous polyposis include:<ref name="pmid10630758">{{cite journal |vauthors=King JE, Dozois RR, Lindor NM, Ahlquist DA |title=Care of patients and their families with familial adenomatous polyposis |journal=Mayo Clin. Proc. |volume=75 |issue=1 |pages=57–67 |year=2000 |pmid=10630758 |doi=10.4065/75.1.57 |url=}}</ref>
*Effective measures for the [[Prevention (medical)|primary prevention]] of familial adenomatous polyposis include genetic counseling.<ref name="pmid10630758">{{cite journal |vauthors=King JE, Dozois RR, Lindor NM, Ahlquist DA |title=Care of patients and their families with familial adenomatous polyposis |journal=Mayo Clin. Proc. |volume=75 |issue=1 |pages=57–67 |year=2000 |pmid=10630758 |doi=10.4065/75.1.57 |url=}}</ref>
**[[Genetic counseling]]
*If there is a family history of specific [[APC (gene)|''APC'' gene]] [[mutation]], all first degree relatives must be tested before puberty.
*The most common method is direct sequencing of the [[APC (gene)|''APC'' gene]].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 20:08, 30 January 2018

Familial adenomatous polyposis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial adenomatous polyposis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial adenomatous polyposis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial adenomatous polyposis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial adenomatous polyposis primary prevention

CDC on Familial adenomatous polyposis primary prevention

Familial adenomatous polyposis primary prevention in the news

Blogs on Familial adenomatous polyposis primary prevention

Directions to Hospitals Treating Familial adenomatous polyposis

Risk calculators and risk factors for Familial adenomatous polyposis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Mohamad Alkateb, MBBCh [3]

Overview

Effective measures for the primary prevention of familial adenomatous polyposis include genetic counseling. The most common method is direct sequencing of the APC gene.

Primary prevention

  • Effective measures for the primary prevention of familial adenomatous polyposis include genetic counseling.[1]
  • If there is a family history of specific APC gene mutation, all first degree relatives must be tested before puberty.
  • The most common method is direct sequencing of the APC gene.

References

  1. King JE, Dozois RR, Lindor NM, Ahlquist DA (2000). "Care of patients and their families with familial adenomatous polyposis". Mayo Clin. Proc. 75 (1): 57–67. doi:10.4065/75.1.57. PMID 10630758.